No abstract available
MeSH terms
-
Anticoagulants / administration & dosage
-
Anticoagulants / adverse effects
-
Benzimidazoles / administration & dosage*
-
Benzimidazoles / adverse effects
-
Brain Ischemia / drug therapy*
-
Brain Ischemia / epidemiology
-
Dabigatran
-
Fibrinolytic Agents / administration & dosage
-
Fibrinolytic Agents / adverse effects
-
Humans
-
Injections, Intravenous / methods
-
Risk Factors
-
Stroke / drug therapy*
-
Stroke / epidemiology
-
Tissue Plasminogen Activator / administration & dosage*
-
Tissue Plasminogen Activator / adverse effects
-
beta-Alanine / administration & dosage
-
beta-Alanine / adverse effects
-
beta-Alanine / analogs & derivatives*
Substances
-
Anticoagulants
-
Benzimidazoles
-
Fibrinolytic Agents
-
beta-Alanine
-
Tissue Plasminogen Activator
-
Dabigatran